We are live on ! Find out more
WEC

Winslow Evans & Crocker Portfolio holdings

AUM $528M
1-Year Est. Return 30.99%
This Fund
S&P 500
This Quarter Est. Return
+5.68%
1 Year Est. Return
+30.99%
3 Year Est. Return
+76.2%
5 Year Est. Return
+147.26%
10 Year Est. Return
AUM
$302M
AUM Growth
-$62.9M
Cap. Flow
-$78M
Cap. Flow %
-25.84%
Top 10 Hldgs %
21.72%
Holding
1,314
New
44
Increased
207
Reduced
571
Closed
197

Top Buys

Rank Stock Value
1
DE icon
Deere & Co
DE
+$481K
2
PYPL icon
PayPal
PYPL
+$408K
3
MCD icon
McDonald's
MCD
+$384K
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$382K
5
SINA
Sina Corp
SINA
+$323K

Sector Composition

Rank Sector Weight
1 Technology 20.31%
2 Healthcare 12.61%
3 Financials 12.48%
4 Consumer Discretionary 8.71%
5 Energy 8.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GSK icon
201
GSK
GSK
$103B
$298K 0.1%
5,870
-332
-5% -$16.8K
STWD icon
202
Starwood Property Trust
STWD
$6.12B
$297K 0.1%
13,676
-3,584
-21% -$79K
CDK
203
DELISTED
CDK Global, Inc.
CDK
$297K 0.1%
4,700
-3,933
-46% -$248K
VTV icon
204
Vanguard Value ETF
VTV
$189B
$294K 0.1%
2,946
-6,683
-69% -$654K
WCN
205
Waste Connections
WCN
$42.8B
$289K 0.1%
4,144
-673
-14% -$44.5K
EPR icon
206
EPR Properties
EPR
$4.86B
$285K 0.09%
4,082
-394
-9% -$27.7K
FMS icon
207
Fresenius Medical Care
FMS
$13.2B
$284K 0.09%
5,800
-7,000
-55% -$333K
PHM icon
208
Pultegroup
PHM
$24.5B
$283K 0.09%
10,340
-1,150
-10% -$29.1K
IDXX icon
209
Idexx Laboratories
IDXX
$42.9B
$280K 0.09%
1,800
-2,100
-54% -$332K
MOAT icon
210
VanEck Morningstar Wide Moat ETF
MOAT
$11.5B
$280K 0.09%
6,936
-4,000
-37% -$158K
BRK.A icon
211
Berkshire Hathaway Class A
BRK.A
$1.07T
$275K 0.09%
2
+1
+100% +$265K
FTV icon
212
Fortive
FTV
$19B
$274K 0.09%
6,140
+2
+0% +$83
SUPN icon
213
Supernus Pharmaceuticals
SUPN
$2.68B
$273K 0.09%
+6,826
New +$295K
ARI
214
Apollo Commercial Real Estate
ARI
$887M
$273K 0.09%
15,060
-2,255
-13% -$40.8K
QABA icon
215
First Trust NASDAQ ABA Community Bank Index Fund
QABA
$92.1M
$272K 0.09%
5,156
-4,748
-48% -$235K
UL icon
216
Unilever
UL
$131B
$271K 0.09%
4,153
-3,555
-46% -$228K
SODA
217
DELISTED
SodaStream International Ltd
SODA
$269K 0.09%
+4,050
New +$236K
SCCO icon
218
Southern Copper
SCCO
$141B
$267K 0.09%
7,234
+7,148
+8,312% +$259K
MO icon
219
Altria Group
MO
$122B
$266K 0.09%
4,194
-5,060
-55% -$337K
SLCA
220
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$266K 0.09%
8,552
-3,178
-27% -$92.1K
FEM icon
221
First Trust Emerging Markets AlphaDEX Fund
FEM
$745M
$261K 0.09%
9,550
+7,550
+378% +$196K
TGT icon
222
Target
TGT
$62.1B
$258K 0.09%
4,366
-1,604
-27% -$89.8K
MSCI icon
223
MSCI
MSCI
$40B
$257K 0.09%
+2,200
New +$244K
ETN icon
224
Eaton
ETN
$157B
$257K 0.09%
3,344
-2,514
-43% -$190K
ETV
225
Eaton Vance Tax-Managed Buy-Write Opportunities Fund
ETV
$1.71B
$254K 0.08%
16,550
-1,100
-6% -$16.9K

Similar funds

Winslow Evans & Crocker's Q3 2017 Portfolio in Review

As of Q3 2017, Winslow Evans & Crocker held 1,314 positions worth $302M, down 17% from $365M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Winslow Evans & Crocker withdrew a net $78M in Q3 2017, closing 197 positions and reducing 571 holdings. Its most notable exit was Veeva Systems, an estimated $619K position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Winslow Evans & Crocker opened a new position in Regeneron Pharmaceuticals worth $358K.

  • Winslow Evans & Crocker's largest Q3 2017 buy was Regeneron Pharmaceuticals: 802 shares worth $358K.
  • Winslow Evans & Crocker added most to Deere & Co in Q3 2017, an estimated $481K increase.
  • Winslow Evans & Crocker's biggest Q3 2017 reduction was Microsoft, cutting an estimated $2.03M.
  • Winslow Evans & Crocker fully exited Veeva Systems in Q3 2017, selling an estimated $619K.
  • Winslow Evans & Crocker's ten largest holdings make up 22% of its $302M portfolio in Q3 2017.
  • Winslow Evans & Crocker opened 44 new positions and closed 197 in Q3 2017.
  • Winslow Evans & Crocker's portfolio value fell 17% quarter-over-quarter to $302M.

Based on Winslow Evans & Crocker's 13F filing for Q3 2017, filed 19 Oct 2017.